TNF Pharmaceuticals (NASDAQ:TNFA) Shares Down 3.4% – Here’s What Happened

by · The Markets Daily

TNF Pharmaceuticals, Inc. (NASDAQ:TNFA – Get Free Report) shares dropped 3.4% on Friday. The company traded as low as $0.4380 and last traded at $0.4404. 113,481 shares changed hands during trading, a decline of 100% from the average daily volume of 32,220,806 shares. The stock had previously closed at $0.4561.

TNF Pharmaceuticals Stock Performance

The firm has a fifty day simple moving average of $1.14 and a 200-day simple moving average of $3.10. The company has a market capitalization of $803,445.00, a PE ratio of -0.00 and a beta of 2.04.

TNF Pharmaceuticals Company Profile

(Get Free Report)

TNF Pharmaceuticals, Inc is a biotechnology company focused on the development of therapies for diseases involving tumor necrosis factor (TNF), a protein associated with inflammation and immune-system activity.

The company’s research and development activities are centered on potential treatments for inflammatory and autoimmune conditions. Detailed information regarding its product pipeline, development stage, commercial operations, geographic reach and leadership is limited.

Further Reading